Last reviewed: June 23, 2026
Last updated: June 23, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
When starting semaglutide for weight loss, your first injection contains 0.25 milligrams—a microdose designed to let your body adapt before advancing to higher therapeutic levels. This gradual approach reduces side effects and improves long-term adherence. Understanding how your treatment begins helps you prepare mentally and physically for the weeks ahead.
Understanding Your First Semaglutide Injection Dose
Your initial semaglutide dose of 0.25 mg activates GLP-1 receptors in your brain's appetite centers without overwhelming your system. This starter dose mirrors the protocol used in clinical trials because it balances appetite suppression with tolerability. Most patients tolerate this opening dose well, though nausea or mild gastrointestinal changes can occur in the first few days.
The 0.25 mg starting point is not a therapeutic dose by itself—it primes your body's metabolic pathways and helps you acclimate to injection-based therapy. By week four, your prescriber evaluates how you've responded before advancing to 0.5 mg. This measured approach ensures your individual tolerance profile guides the entire treatment journey.
The Four-Week Escalation Schedule for Semaglutide
Semaglutide follows a standardized four-week titration protocol: 0.25 mg in week one, then 0.5 mg in week two, 1.0 mg in week three, and 1.7 mg or 2.4 mg by week four. This weekly increase allows your body to adapt incrementally while tracking appetite changes and side effect patterns. Most people feel meaningful appetite suppression between weeks two and three as the dose climbs.
Your prescriber may pause increases if you experience significant nausea, constipation, or other side effects—this is normal and encouraged. Some patients benefit from staying at 1.0 mg or 1.7 mg longer before advancing, depending on their weight loss progress and symptom burden. PlexusDx providers customize this timeline based on your individual response, not a fixed schedule.
How PlexusDx Personalizes Your Semaglutide Starting Dose
While the 0.25 mg starter dose is standard, PlexusDx personalizes your entire dosing journey through baseline health assessment and optional genetic testing. The Precision Peptide Genetic Test identifies your GLP1R and GIPR variants—key receptors that influence how strongly your body responds to semaglutide. Patients with certain genetic signatures may reach effective appetite suppression at lower cumulative doses, while others benefit from advancing more quickly.
PlexusDx providers also consider your baseline BMI, metabolic history, and prior medication tolerances when structuring your dose increases. If you have a sensitive GI system or take medications that slow digestion, your prescriber might extend the four-week intervals to five or six weeks. This individualized approach prevents unnecessary discomfort and improves the likelihood you'll stay engaged with treatment.
Your Dose May Rise, But Your PlexusDx Price Won't
PlexusDx compounded semaglutide injection starts at $149 per month—a flat rate that covers your entire dose escalation from 0.25 mg through your maintenance dose. This pricing model removes the financial uncertainty that comes with traditional dose-ladder systems where price jumps as milligrams increase. Whether you're injecting 0.5 mg or 2.4 mg, your monthly cost remains predictable.
Compounded semaglutide from PlexusDx's licensed 503A pharmacies meets the same pharmaceutical standards as brand-name options, with no insurance requirement or membership fees. HSA and FSA accounts can cover your monthly cost, and PlexusDx serves all 50 states. This transparent pricing structure lets you focus on your health improvements rather than worrying about escalating out-of-pocket costs.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the typical starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected once weekly. This low dose allows your body to adapt to GLP-1 therapy and minimizes side effects while activating appetite-suppressing pathways. Your dose increases every four weeks until you reach an effective maintenance level, typically 1.7 mg to 2.4 mg weekly.
Why does semaglutide start so low if 2.4 mg is the therapeutic dose?
Starting at 0.25 mg prevents sudden nausea, vomiting, and gastrointestinal distress that would derail treatment adherence. Clinical trials show that gradual titration improves long-term weight loss outcomes and tolerability compared to jumping straight to higher doses. Your body needs time to stabilize GLP-1 receptor signaling before handling maximum appetite suppression.
Does PlexusDx charge more if my semaglutide dose increases?
No. PlexusDx compounded semaglutide injection starts at $149 per month and maintains that flat rate throughout your entire dose escalation. Your dose may rise from 0.25 mg to 2.4 mg, but your monthly cost stays the same—removing financial barriers to reaching your optimal therapeutic level.
What side effects should I expect when starting semaglutide?
Common early side effects include mild nausea, reduced appetite, and possible constipation or diarrhea during the first one to two weeks. Most side effects improve by week three as your body adjusts. Staying hydrated, eating protein-rich meals, and moving your body daily can significantly reduce nausea intensity.
Can the PlexusDx Precision Peptide Genetic Test help predict my semaglutide response?
Yes. The test identifies your GLP1R rs6923761 and GIPR rs1800437 variants—genetic markers that influence how sensitively your receptors respond to semaglutide. Patients with certain variants may experience appetite suppression at lower doses, helping PlexusDx providers tailor your starting and escalation schedule for faster, more comfortable results. The test costs $99 as an add-on after your first month.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Weight Loss and ADHD Medication: Can You Take Ozempic with ADHD Medication?
Is Ozempic Recommended for Weight Loss?